FY ended March 2026
- Japan: Sales decreased 0.6%. The Company concentrated on enhancing sales activities which match each market; the acute care hospital market, the small and mid-sized hospital market, and the clinic market. The Company also focused on its consumables and services business as well as strengthening its marketing and service capabilities, creating customer value which contributed to improving medical safety, patient outcomes, and operating efficiency. Domestic sales decreased due to restraining sales of locally purchased products and lower sales of Abbott products. Sales of AEDs decreased in the PAD (public access defibrillation) market mainly due to inventory adjustment at distributors. Sales in the public hospital market also decreased, while sales in the university, private hospital, and clinic markets increased. Sales of Treatment Equipment and Patient Monitors decreased, while sales of Physiological Measuring Equipment and Other Medical Equipment increased.
- International: Sales increased 13.1%. Sales achieved double-digit growth, because sales in all regions increased favorably. Overseas sales also increased favorably on a comparable basis excluding the currency effect and the impact of the consolidation of Ad-Tech. Sales of Physiological Measuring Equipment and Treatment Equipment increased significantly. Sales of Patient Monitors and Other Medical Equipment decreased.
(Years ended March 31, million yen)
|
2022 |
2023 |
2024 |
2025 |
2026 |
|
|
Domestic Sales |
136,321 |
135,734 |
142,370 |
145,237 |
144,406 |
|
Overseas Sales (Overseas Sales Ratio) |
68,807 (33.5%) |
70,869 (34.3%) |
79,615 (35.9%) |
80,187 (35.6%) |
90,693 (38.6%) |
|
Total |
205,129 |
206,603 |
221,986 |
225,424 |
235,099 |
FY ended March 2026
- North America: Sales increased 18.9%. Sales showed double-digit growth, posting a significant increase in sales of neurology products including Ad-Tech as well as favorable sales of ventilators and AEDs. Sales of Patient Monitors decreased compared to the strong growth in FY2024, while sales in the fourth quarter achieved double-digit growth.
- Latin America: Sales increased 4.2%. Sales increased both on a yen basis and on a local currency basis, as sales in the fourth quarter achieved double-digit growth. Sales increased mainly in Paraguay and Peru.
- Europe: Sales increased 8.7%. Sales increased favorably, especially in Turkey, the U.K., and Italy.
- Asia & Other: Sales increased 6.3%. Sales increased favorably, especially in Southeast Asia, India, and the Middle East & Africa.
Overseas Sales Composition by Geographic Segments
in FY ended March 2026
Overseas Sales by Geographic Segments
Years ended March 31
(Years ended March 31, million yen)
|
2022 |
2023 |
2024 |
2025 |
2026 |
|
|
Americas |
33,436 |
36,818 |
43,097 |
47,288 |
55,422 |
|
North America |
- |
32,303 |
37,058 |
41,900 |
49,808 |
|
Latin America |
- |
4,514 |
6,039 |
5,388 |
5,613 |
|
Europe |
11,449 |
12,349 |
13,104 |
12,554 |
13,649 |
|
Asia & Other |
23,921 |
21,701 |
23,413 |
20,344 |
21,621 |
|
Total |
68,807 |
70,869 |
79,615 |
80,187 |
90,693 |
* Effective FY ended March 2024, sales in the Americas are disclosed separately for sales in North America and Latin America.
